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extremely rare, always associated with clinical symptoms, 
and rarely detected by blood gas analysis.  Conclusion: Ac-
cording to our data a decreasing weight SDS for age is a suf-
ficient indication to perform blood gas analysis in children 
 ! 3 years of age, particularly in the presence of additional 
clinical features, whereas it can be omitted in short children 
 1 3 years of age.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 For early diagnosis of medical conditions that lead to 
growth failure, regular monitoring of growth in terms of 
length (between 0 and 2 years) or height (from 2 years 
onward) and weight is needed, as well as an evidence-
based guideline on referral criteria. After referral, a thor-
ough medical history and physical examination followed 
by screening laboratory tests are essential to detect disor-
ders that may present without clinical symptoms and 
signs.
 We have recently proposed auxological referral crite-
ria with a good sensitivity (beyond the age of 3 years) to 
detect Turner syndrome and various other growth disor-
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 Abstract 
 Background: Renal tubular acidosis (RTA) is a rare cause of 
growth failure, therefore it is uncertain whether routine 
screening with blood gas analysis of short infants and chil-
dren is cost-effective.  Objective: To investigate the clinical, 
growth and laboratory parameters in children with RTA to 
estimate the possible value of laboratory screening for this 
disorder in infants and children referred for short stature ac-
cording to a recent guideline.  Method: Retrospective chart 
analysis of 30 children diagnosed between 1978 and 2005 in 
The Netherlands and 3 centers in Belgium.  Results: The cur-
rent guideline for short stature detected 33% of children 
with RTA. Assuming a pre-test probability of RTA of 0.6 per 
100,000 births, the likelihood ratio of poor growth was 58 
and 17 below and above 3 years, respectively. Sensitivity was 
17/30 and 12/24 for a –2.0 SDS cutoff for weight and body 
mass index, respectively. In infants and toddlers diagnosed 
before 3 years of age, the mean weight loss was 1.5 SD, and 
0.8 SDS in older children. In short children  1 3 years RTA was 
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ders at a specificity of approximately 99%  [1] . We have 
also tested this guideline for its effectiveness in detecting 
celiac disease and cystic fibrosis, which showed that the 
change in body mass index is a better marker to detect 
both conditions, although the sensitivity is still low (ap-
proximately 30%)  [2, 3] .
 Among children referred for failure to thrive or im-
paired growth, renal tubular acidosis (RTA) is one of the 
diagnostic considerations. Failure to thrive and/or growth 
retardation are often observed in this disease  [4–6] , thus 
one might consider testing for RTA through blood gas 
analysis (acid-base equilibrium). In fact, a blood gas anal-
ysis was included in the Dutch consensus-based guide-
line  [7] . However, RTA is a rare condition, and in a retro-
spective analysis of 742 short children no case with RTA 
was found (although the compliance with the guideline 
was far from optimal)  [8] . Among pediatric endocrinolo-
gists there is no worldwide consensus about including 
this test in the screening procedure for growth failure: 
only 32% of the participating pediatric endocrinologists 
considered blood gas analysis important in the evalua-
tion of a child with failure to thrive  [9] .
 In an effort to establish whether a blood gas analysis is 
indicated in the workup of growth failure, including fail-
ure to thrive, we investigated growth in patients diag-
nosed with RTA and compared this with the auxological 
referral criteria for growth failure.
 Patients and Methods 
 We performed a retrospective chart analysis of all known 
Dutch patients and patients from 3 Belgian centers in whom the 
diagnosis of RTA had been made between 1978 and 2005. We 
estimated the number of births per year in this area at 200,000 
per year, based on birth statistics in The Netherlands and Flan-
ders. For this analysis growth data before and at diagnosis were 
analyzed. Length and height data were transformed to standard 
deviation scores (SDS; HSDS)  [10] . Target height (TH) was cal-
culated according to the Tanner formula (midparental height 
 8 6.5) with an additional correction for secular trend (4.5 cm/
generation) and expressed as SDS: (TH – 184)/7.1 for males and 
(TH – 170.6)/6.5 for females  [10] . The length and height data of 
each patient were compared with the auxological criteria of the 
new guideline  [1] . Weight data were collected and transformed 
to SDS (WSDS). Where appropriate the change in WSDS from 
its maximal value until WSDS at diagnosis was calculated. Body 
mass index (BMI) was calculated by weight/height squared and 
also expressed as SDS  [11] . Finally, selected laboratory data at 
diagnosis were studied. RTA was diagnosed based on estab-
lished criteria, including a low pH ( ! 7.35), a low plasma bicar-
bonate ( ! 21 mmol/l), elevated serum chloride ( 1 106), and/or 
urine pH  1 5.3.
Table 1.  Characteristics of RTA patients at diagnosis: auxology
Parameter at diagnosis n Median (range) Mean8SD
Age, years 30 0.5 (0 to16.6)
HSDS 30 –2.0 (–5.5 to 1.3)
HSDS – THSDS 18 –1.281.8
WSDS 30 –2.381.7
BMI SDS 24 –2.281.7
S DS = Standard deviation score; HSDS = height or length SDS; 
THSDS = target height SDS; WSDS = weight SDS; BMI = body 
mass index.
Table 2.  Characteristics of RTA patients at diagnosis: biochemical 
data
Pa-
tient
No.
Age at 
diagnosis
years
Sex RTA
type
pH
blood
Bicarb.
blood
mmol/l
pH
urine
Cl-
blood
mEq/l
1 0.01 M ND 7.35 13.4 NA 111
2 0.01 M D 7.33 17.0 9.00 NA
3 0.02 M ND NA 17.4 5.00 113
4 0.07 M D 7.21 12.7 7.08 109
5 0.07 F D 7.26 17.0 8.00 106
6 0.07 F D 7.14 12.2 7.55 111
7 0.08 F D 7.43 23.5 8.30 104
8 0.19 F D NA 14.6 7.00 108
9 0.21 F D 7.22 11.0 7.00 145
10 0.24 M D 7.39 9.0 7.70 124
11 0.33 M D 7.22 14.9 8.00 NA
12 0.37 M D 7.27 9.4 NA 108
13 0.40 F D 7.40 15.9 7.00 110
14 0.43 M D 7.34 14.2 6.00 112
15 0.47 F D 7.37 22.0 7.00 115
16 0.51 F D 7.38 19.5 6.00 111
17 0.58 F ND 7.30 16.3 7.40 112
18 1.12 M D 7.26 9.3 5.00 104
19 1.21 F D 7.41 19.0 6.50 106
20 1.37 M D 7.39 20.0 7.00 108
21 1.56 M D 7.27 16.0 7.40 113
22 1.57 F D 7.37 17.0 8.50 107
23 1.79 F D 7.39 18.1 9.00 117
24 3.09 F D 7.44 20.0 7.00 100
25 4.54 M D 7.39 23.3 8.00 110
26 5.41 F P 7.42 22.8 5.10 102
27 7.63 M incom-
plete D
7.38 23.2 6.20 107
28 9.33 F D 7.41 22.4 5.90 113
29 14.58 F D 7.40 25.9 6.70 103
30 16.64 F D 7.37 20.3 8.00 104
D = Distal; P = proximal; ND = type not defined; Cl = serum 
chloride; NA = not available.
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 Results 
 General Characteristics 
 Data of 33 patients (14 males) were obtained, but in 3 
patients the data were incomplete and unsuitable for an-
swering the study questions. Therefore, we used the data 
of 30 patients (13 males). A summary of the patient data 
is provided in  tables 1 and  2 . RTA was diagnosed before 
the age of 3 years in 23 children. Twenty-six patients had 
distal RTA, 1 proximal, and 3 were undefined. In 19 pa-
tients, blood pH was not  ! 7.35. In these children, 12 had 
low bicarbonate levels according to the definition, 6 had 
urine pH  1 5.3, and in the final patient urine pH was just 
below 5.3, whereas the NH 4 excretion was abnormal in a 
specific test.
 Comparison with the Referral Guideline for Length or 
Height 
 For each patient growth was compared with the deci-
sion rules from the new referral guideline, in order to as-
sess whether the children with RTA would have come un-
der medical attention when only their growth pattern was 
taken into account.
 For infants  and toddlers  ! 3 years of age the referral 
criteria (HSDS  ! –3 SDS or repeatedly below –2.5 SDS) are 
very strict to prevent too many false-positives. Of the 23 
children diagnosed before 3 years of age, 5 had a HSDS 
 ! –3 and 3 a HSDS repeatedly  ! –2.5. The growth patterns 
of the remaining 15 children did not fulfill the referral 
criteria ( fig. 1 ). If a HSDS of  ! –2 was as a criterion, 11 of 
23 children would be referred.
<
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 Fig. 1. The number of patients whose growth characteristics complied with the guideline for referral of short 
children. Growth data from patients with RTA were compared with the evidence-based guideline  [1] . The num-
bers of patients  !  and  6 3 years of age from this study are given in gray squares. 
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 Of the 7 children diagnosed  6 3 years of age, only 2 
had a height SDS of  ! –2.5 and would therefore be re-
ferred. One patient had a HSDS between –2.5 and –2, but 
did not show height below the TH range or a growth de-
flection. The remaining 4 children had a HSDS of  1 –2.0 
( fig. 1 ). Thus, the sensitivity of the referral criteria to de-
tect RTA is only (8 + 2)/30 = 33%.
 If one would assume that we have been able to col-
lect all RTA patients born in a period of 28 years, the
pretest probability of RTA can be estimated at 33 per 
5,600,000 = 5.9 per 100,000 births. The 2 ! 2 contingency 
table for the new auxological guideline in children  ! 3 
years is shown in  table 3 . The positive predictive value is 
3 per 10,000, and the likelihood ratio for a positive result 
(LR+) is 58 (95% CI 33–102). For children  6 3 years, where 
both the sensitivity (2/7 = 29%) and specificity (98.3) are 
lower  [1] , the LR+ is 17 (95% CI 5–54).
 Weight for Age and BMI 
 In patients diagnosed before 3 years of age, 14 of 23 had 
a WSDS of  ! –2 at diagnosis, and in older patients 3 of 7 
(total 17/30). Only 2 patients had a weight of  1 0 SDS. In 
children  ! 3 years, mean weight loss in the period prior to 
diagnosis, expressed as the difference between maximal 
WSDS and WSDS at diagnosis, was 1.5 SDS (SD 1.0, n = 
12), and in the older age group median weight loss was 0.8 
SDS (range 0.1–2.2, n = 6). Overall, the median weight 
loss was 1.2 (range 0.1–3.3, n = 18; in some patients diag-
nosed shortly after birth no reliable loss in weight could 
be calculated). The correlation between age at diagnosis 
and WSDS at diagnosis was 0.26 (NS), while the correla-
tion between age at diagnosis and weight loss was –0.47 
(p  ! 0.05; n = 18;  fig. 2 ,  3 ). This suggests that weight loss 
might be an additional parameter in infants and toddlers 
Table 3.  2!2 contingency table showing estimates of positive and 
negative test results for RTA if the guideline for referral of growth 
failure were to be used for children <3 years
Test RTA No disease Total
Positive 8 23,418 23,426
Negative 15 3,879,589 3,879,604
Total 23 3,903,007 3,903,030
S ensitivity = 8/23 = 0.35.
Number of false-positives = 0.06 ! 3,903,007 = 23,418.
Prevalence of disease (diagnosed at <3 years; pretest probabil-
ity) = 23/3,903,030 = 0.59/100,000.
Positive predictive value = 8/23,418 = 0.00034 (3.4 per 10,000, 
95% CI 1–6 per 10,000).
Likelihood ratio for a positive result (LR+) = se/(1 – sp) = 58 
(95% CI 33–102).
Likelihood ratio for a negative result (LR–) = (1 – se)/sp = 0.66 
(95% CI 0.49–0.88).
The total number of children born in 28 years corrected for the 
RTA patients who were diagnosed before 3 years of age was esti-
mated at 23/33 ! 5,600,000 = 3,903,030. The specificity of the 
guideline is 99.4% [1].
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 Fig. 2. Scatterplot of weight SDS versus age at diagnosis in 30 chil-
dren; r = 0.26 (NS). 
 Fig. 3. Scatterplot of weight loss in the period previous to diagno-
sis versus age at diagnosis (n = 18, r = –0.47, p  ! 0.05). 
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for the diagnosis of RTA. However, the numbers of pa-
tients are small, and the difference between both age 
groups did not reach statistical significance.
 In 6 children BMI could not be calculated due to young 
age ( ! 2 months) at diagnosis. In the other 24 children 
mean BMI SDS at diagnosis was –2.2 (range –5.9 to +1.0 
SDS, SD 1.7). In patients diagnosed before 3 years of age, 
10 of 17 had a BMI SDS of  ! –2, and in older patients 2 of 
7. The difference in BMI SDS at diagnosis between the 
youngest and older age group did not reach statistical sig-
nificance, although the younger children tended to have 
lower BMI SDS. The number of children who complied 
with the decision rule that proved most effective for ce-
liac disease and cystic fibrosis (combining BMI SDS of 
 ! –2 and change in BMI of  1 0.5/year)  [2, 3] was 7/9.
 Combination of Auxological Parameters 
 If one single auxological criterion was chosen, in chil-
dren  ! 3 years a WSDS of  ! –2 would yield the highest 
sensitivity (14/23, 61%), and sensitivity would increase to 
15/23 (65%) if HSDS or WSDS were  ! –2. In older children 
a height SDS of  ! –2 would result in a sensitivity of 3/7 
(43%), and this would increase to 4/7 (57%) if HSDS or 
BMI SDS were  ! –2. A similar result would be obtained if 
WSDS or BMI SDS were  ! –2.
 Clinical Presentation and Blood Gas Analysis 
 There are two additional factors that have to be taken 
into account before the decision is made to perform blood 
gas analysis in infants and children with failure to thrive 
or other forms of growth failure: (1) how often growth 
failure was the only presenting symptom, and (2) the di-
agnostic value of blood gas analysis.
 In children  ! 3 years, 4 of 23 had a blank medical his-
tory besides failure to thrive or another form of growth 
failure. Other reasons for referral were a positive family 
history for RTA, renal stones, recurrent urinary tract in-
fections, constipation or vomiting. In the 7 children di-
agnosed at 3 years of age or older, none was symptom-free 
at diagnosis. Symptoms included bowing of the legs, 
tiredness, recurrent infections of the urinary tract and 
renal stones.
 As shown in  table 2 , the diagnostic value of blood gas 
analysis is reasonable in infants (only 2 of 23 cases had an 
initial normal result, defined as pH  1 7.35 and a bicarbon-
ate  1 21). However, in older children, only in 2 of 7 was 
bicarbonate slightly decreased and pH was always  1 7.35. 
Thus, blood gas analysis has a low diagnostic validity in 
that age group.
 Discussion 
 We have shown that in children  ! 3 years of age the 
referral guideline, based on length data alone, has a posi-
tive likelihood ratio of 58, suggesting that the guideline 
is a useful tool for screening of children with RTA. How-
ever, the sensitivity to detect children with RTA is low, as 
a considerable percentage of children (15/23) would not 
have been diagnosed by monitoring growth alone ac-
cording to the guidelines. Weight and weight loss appear 
better markers. However, most infants present not only 
with growth failure, but also with one of the other signs 
or symptoms associated with RTA. Blood gas analysis 
was abnormal in 21/23 cases. In contrast, in children old-
er than 3 years the prevalence of RTA is considerably low-
er, the percentage of children with poor growth detected 
by applying the guideline is lower (2 of 7), all children had 
additional signs and symptoms, and the diagnostic value 
of the blood gas analysis was low. This means that screen-
ing all asymptomatic short children of  1 3 years using 
blood gas analysis would not be cost-effective.
 Among the many causes of failure to thrive or im-
paired growth, renal disease is an important category to 
consider. On the one hand, chronic renal insufficiency 
may lead to impaired growth  [12] , but chronic states of 
acidosis, as in RTA, are also known to induce growth re-
tardation  [4, 13] . Acidosis in RTA may be caused by: (1) 
tubular failure to secrete hydrogen ions by the distal con-
voluted tubule; (2) urinary bicarbonate wasting due to 
proximal convoluted failure, or (3) a mixed mechanism. 
The diagnosis and classification of RTA have tradition-
ally been based on functional studies. In the last decade, 
application of molecular biology techniques has opened 
a new perspective to the understanding of the pathophys-
iology of inherited causes of RTA. Gene mutations have 
been identified in RTA combined with ocular abnormal-
ities and sensorineural deafness (SLC4A4 and ATP6B, re-
spectively)  [14] . However, in the human, none of these 
genes was linked to disturbances in the growth axis.
 The mechanism of failure to thrive in RTA is not com-
pletely understood. In the older literature it was observed 
that treatment of the acidosis per se led to improvement 
of growth, suggesting an inhibitory effect of acidosis on 
growth  [15] . In contrast, Glaser et al.  [16] suggested a role 
for growth hormone in maintaining normal acid-base 
homeostasis, and thus growth hormone deficiency should 
be considered in cases of acidosis and growth failure. 
Based on literature from the 1970s, Tsuru and Chan  [17] 
suggested that growth failure in acidosis is probably re-
lated to disturbances in vitamin D and calcium metabo-
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lism. This was not in accordance with later studies as 
summarized by Donckerwolcke et al.  [4] who also dis-
cussed the inconsistent findings on either impaired or 
normal growth hormone secretion during acidosis. More 
recently, Mitch  [18] summarized the metabolic and clin-
ical consequences of metabolic acidosis. He concluded 
that abnormalities in the GH-IGF axis occur due to aci-
dosis (e.g. blunted IGF-1 response to GH). However, some 
data are derived from animal studies and contrast with 
human adult data, so that the applicability to the situa-
tion in children is uncertain.
 In order to trace children with RTA as early as possi-
ble, the clinician should be alert to failure to thrive and 
other RTA symptoms (nausea, vomiting, weight loss, a 
positive family history, nephrocalcinosis, renal stones, 
rickets and bone demineralization), and be aware that the 
guideline for growth monitoring only detects a small per-
centage of cases. We obtained similar findings in two 
other diseases that can be detected at an early age by fail-
ure to thrive: celiac disease and cystic fibrosis  [2, 3] . In 
studies on the best decision rules that could be applied to 
detect these conditions, we showed that the overall per-
formance of detecting both disorders with statural 
growth parameters is moderate, and that in the first year 
of life weight is a better auxological tool for detection than 
length  [2, 3] . Furthermore, the  deflection  of weight and 
BMI is more important than weight or BMI SDS per se.
 Concerning weight, we observed that a decrease in 
WSDS in the period prior to diagnosis is more marked in 
the younger age group. Apparently, weight loss is a stron-
ger marker of disease in young infants. Using the de-
crease in weight as a criterion for referral, a decrease in 
weight of 1.5 SDS would lead to referral of more than 50% 
of RTA patients, but only in the group  ! 3 years. Weight 
loss seems to play a lesser role in the clinical course of 
older children. The combination of several auxological 
criteria had no additional value when compared with the 
use of only 1 parameter. Weight appeared to be a more 
sensitive predictor of RTA than length.
 A limitation of this study is the small number of pa-
tients, incomplete data, and the retrospective design. Al-
though we presume that we included all patients in The 
Netherlands and in 3 Belgian centers, possibly several 
older children with a mild phenotype may not have been 
included in the study. Still, it will be difficult to collect a 
larger dataset, and we believe that our results are repre-
sentative for RTA patients in other geographic areas. A 
second limitation is that the rarity of the disease leads to 
a very low probability before any clue from the medical 
history, growth and physical examination is taken into 
account. However, most patients did have some symp-
toms, which increases the pretest probability. Further-
more, the pretest probability would be much higher in 
patients with a family history of RTA than for those with 
nonspecific symptoms. A third limitation is that there is 
admittedly some degree of subjectivity in the interpreta-
tions of the various likelihood ratios, and therefore it re-
mains uncertain how these data can be translated to cost-
effectiveness.
 In conclusion, the proposed auxological guideline 
only detects one third of children with RTA. A cutoff for 
weight or BMI SDS has a better sensitivity, similar to our 
previous findings in celiac disease and cystic fibrosis. In 
children  ! 3 years a decreasing weight for age is a suffi-
cient indication to perform blood gas analysis, particu-
larly in the presence of additional clinical features. This 
laboratory measure can be omitted in asymptomatic 
short children  6 3 years, because of the extremely low 
prevalence of RTA in that age group, and the low sensitiv-
ity of growth failure and blood gas analysis.
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